Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril for Peripheral Arterial Disease
NCT00681226Phase 4Completed
- Start
- Jan 2008
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Peripheral Arterial Disease (PAD) comparing Ramipril with Placebo (2 arms). Primary endpoints: Pain-free walking time at 6 months and Maximum walking time at 6 months. Started Jan 2008; status: completed.
02
Drugs
ramipril
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT00681226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00681226.